This study is testing a new eye drop called QLS-111 for people with normal tension glaucoma, a type where eye pressure is not high. It will compare the safety and ability to lower eye pressure of QLS-111 against a standard eye drop (timolol). The trial involves about 36 participa…
Phase: PHASE2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC